

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.54319325 |
| 2 | actin-mediated cell contraction (GO:0070252) | 6.87934590 |
| 3 | skeletal muscle contraction (GO:0003009) | 6.65017901 |
| 4 | creatine metabolic process (GO:0006600) | 6.02936304 |
| 5 | striated muscle contraction (GO:0006941) | 5.69630778 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 5.66142744 |
| 7 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.31348709 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 5.20959367 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.20959367 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.12631265 |
| 11 | actin filament-based movement (GO:0030048) | 5.10982017 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.09198349 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.09198349 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.90758639 |
| 15 | regulation of cell communication by electrical coupling (GO:0010649) | 4.75352153 |
| 16 | lysine metabolic process (GO:0006553) | 4.74787985 |
| 17 | lysine catabolic process (GO:0006554) | 4.74787985 |
| 18 | regulation of actin filament-based movement (GO:1903115) | 4.64171362 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.62457815 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.61241008 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.60315873 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 4.58312433 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.57545061 |
| 24 | response to muscle activity (GO:0014850) | 4.55731064 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.51872018 |
| 26 | NADH metabolic process (GO:0006734) | 4.49451922 |
| 27 | 2-oxoglutarate metabolic process (GO:0006103) | 4.44402821 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.44071095 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.34955988 |
| 30 | skeletal muscle fiber development (GO:0048741) | 4.34273210 |
| 31 | cardiac muscle hypertrophy (GO:0003300) | 4.34011847 |
| 32 | carnitine shuttle (GO:0006853) | 4.31352986 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 4.29609243 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.28431791 |
| 35 | * muscle contraction (GO:0006936) | 4.25795511 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.21832148 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 4.21091551 |
| 38 | sarcomere organization (GO:0045214) | 4.20179259 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.17043777 |
| 40 | striated muscle hypertrophy (GO:0014897) | 4.14813196 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14747950 |
| 42 | bile acid biosynthetic process (GO:0006699) | 4.14080057 |
| 43 | tryptophan catabolic process (GO:0006569) | 4.12889892 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 4.12889892 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 4.12889892 |
| 46 | fatty acid beta-oxidation (GO:0006635) | 4.04712263 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.02434782 |
| 48 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.99255286 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.93293136 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 3.91551011 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 3.90439494 |
| 52 | glycogen catabolic process (GO:0005980) | 3.88902820 |
| 53 | myotube cell development (GO:0014904) | 3.88866826 |
| 54 | cardiac myofibril assembly (GO:0055003) | 3.85775572 |
| 55 | tryptophan metabolic process (GO:0006568) | 3.85540497 |
| 56 | response to inactivity (GO:0014854) | 3.85447297 |
| 57 | * muscle system process (GO:0003012) | 3.85241483 |
| 58 | short-chain fatty acid metabolic process (GO:0046459) | 3.84644951 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.82379124 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.81597355 |
| 61 | actomyosin structure organization (GO:0031032) | 3.79488957 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76352612 |
| 63 | protein carboxylation (GO:0018214) | 3.76352612 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.75509602 |
| 65 | muscle hypertrophy (GO:0014896) | 3.75266339 |
| 66 | serine family amino acid catabolic process (GO:0009071) | 3.74173709 |
| 67 | regulation of protein activation cascade (GO:2000257) | 3.73496761 |
| 68 | fatty acid oxidation (GO:0019395) | 3.71946396 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.71225455 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.71171639 |
| 71 | tricarboxylic acid cycle (GO:0006099) | 3.70989341 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 3.70733888 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69715159 |
| 74 | lipid oxidation (GO:0034440) | 3.69229202 |
| 75 | protein-lipid complex remodeling (GO:0034368) | 3.68648923 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.68648923 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.68648923 |
| 78 | fatty acid catabolic process (GO:0009062) | 3.68250412 |
| 79 | cysteine metabolic process (GO:0006534) | 3.64314388 |
| 80 | neuronal action potential propagation (GO:0019227) | 3.63922724 |
| 81 | ketone body metabolic process (GO:1902224) | 3.63174146 |
| 82 | regulation of sequestering of triglyceride (GO:0010889) | 3.63128317 |
| 83 | glucan catabolic process (GO:0009251) | 3.62681051 |
| 84 | cardiac muscle adaptation (GO:0014887) | 3.62672619 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.62672619 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 3.62672619 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.59926114 |
| 88 | carnitine metabolic process (GO:0009437) | 3.59061080 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 3.58814231 |
| 90 | ethanol oxidation (GO:0006069) | 3.58562733 |
| 91 | myofibril assembly (GO:0030239) | 3.58340374 |
| 92 | urea cycle (GO:0000050) | 3.58145177 |
| 93 | urea metabolic process (GO:0019627) | 3.58145177 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.57407076 |
| 95 | striated muscle adaptation (GO:0014888) | 3.56615134 |
| 96 | muscle filament sliding (GO:0030049) | 3.54175890 |
| 97 | actin-myosin filament sliding (GO:0033275) | 3.54175890 |
| 98 | homocysteine metabolic process (GO:0050667) | 3.54022994 |
| 99 | plasma membrane repair (GO:0001778) | 3.53370208 |
| 100 | acylglycerol homeostasis (GO:0055090) | 3.52454587 |
| 101 | triglyceride homeostasis (GO:0070328) | 3.52454587 |
| 102 | regulation of complement activation (GO:0030449) | 3.50907348 |
| 103 | regulation of fatty acid oxidation (GO:0046320) | 3.49802742 |
| 104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.49025912 |
| 105 | plasma lipoprotein particle clearance (GO:0034381) | 3.48776089 |
| 106 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.48294413 |
| 107 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.48294413 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 3.48276322 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 3.47467249 |
| 110 | bile acid metabolic process (GO:0008206) | 3.47368206 |
| 111 | skeletal muscle adaptation (GO:0043501) | 3.47241674 |
| 112 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46646653 |
| 113 | regulation of striated muscle contraction (GO:0006942) | 3.45706435 |
| 114 | phospholipid efflux (GO:0033700) | 3.44818654 |
| 115 | coenzyme catabolic process (GO:0009109) | 3.44361527 |
| 116 | glucan biosynthetic process (GO:0009250) | 3.43640361 |
| 117 | glycogen biosynthetic process (GO:0005978) | 3.43640361 |
| 118 | carnitine transmembrane transport (GO:1902603) | 3.39169841 |
| 119 | cellular modified amino acid catabolic process (GO:0042219) | 3.37954448 |
| 120 | response to mercury ion (GO:0046689) | 3.36799854 |
| 121 | valine metabolic process (GO:0006573) | 3.36392318 |
| 122 | glutamate metabolic process (GO:0006536) | 3.35994488 |
| 123 | cellular polysaccharide catabolic process (GO:0044247) | 3.35893520 |
| 124 | positive regulation of lipid catabolic process (GO:0050996) | 3.33599587 |
| 125 | fructose metabolic process (GO:0006000) | 3.33062384 |
| 126 | regulation of skeletal muscle contraction (GO:0014819) | 3.32587236 |
| 127 | organic acid catabolic process (GO:0016054) | 3.31215840 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 3.31215840 |
| 129 | nitrogen cycle metabolic process (GO:0071941) | 3.31146174 |
| 130 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.30950348 |
| 131 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.30950348 |
| 132 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.30256510 |
| 133 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.29042763 |
| 134 | aromatic amino acid family metabolic process (GO:0009072) | 3.27011363 |
| 135 | regulation of membrane repolarization (GO:0060306) | 3.25520247 |
| 136 | muscle fiber development (GO:0048747) | 3.23906269 |
| 137 | regulation of the force of heart contraction (GO:0002026) | 3.22758418 |
| 138 | negative regulation of sterol transport (GO:0032372) | 3.22022672 |
| 139 | negative regulation of cholesterol transport (GO:0032375) | 3.22022672 |
| 140 | carnitine transport (GO:0015879) | 3.21075945 |
| 141 | amino-acid betaine transport (GO:0015838) | 3.21075945 |
| 142 | low-density lipoprotein particle remodeling (GO:0034374) | 3.17178512 |
| 143 | biotin metabolic process (GO:0006768) | 3.17062904 |
| 144 | gluconeogenesis (GO:0006094) | 3.16725715 |
| 145 | skeletal muscle tissue development (GO:0007519) | 3.16625455 |
| 146 | tyrosine metabolic process (GO:0006570) | 3.16233450 |
| 147 | cardiac muscle contraction (GO:0060048) | 3.16119367 |
| 148 | cellular glucuronidation (GO:0052695) | 3.15590538 |
| 149 | branched-chain amino acid metabolic process (GO:0009081) | 3.14801893 |
| 150 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11123117 |
| 151 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.09679171 |
| 152 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.09033115 |
| 153 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.07671134 |
| 154 | oxaloacetate metabolic process (GO:0006107) | 3.06408911 |
| 155 | muscle tissue morphogenesis (GO:0060415) | 3.05349376 |
| 156 | adult heart development (GO:0007512) | 3.05277670 |
| 157 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.05023773 |
| 158 | polysaccharide catabolic process (GO:0000272) | 2.99723287 |
| 159 | relaxation of muscle (GO:0090075) | 2.90466244 |
| 160 | positive regulation of synapse maturation (GO:0090129) | 2.89507535 |
| 161 | muscle adaptation (GO:0043500) | 2.89389540 |
| 162 | cell communication by electrical coupling (GO:0010644) | 2.84337555 |
| 163 | hexose biosynthetic process (GO:0019319) | 2.83876768 |
| 164 | glycogen metabolic process (GO:0005977) | 2.83594254 |
| 165 | muscle cell cellular homeostasis (GO:0046716) | 2.78917826 |
| 166 | positive regulation of myotube differentiation (GO:0010831) | 2.77496952 |
| 167 | cellular glucan metabolic process (GO:0006073) | 2.77045837 |
| 168 | glucan metabolic process (GO:0044042) | 2.77045837 |
| 169 | heart contraction (GO:0060047) | 2.76775609 |
| 170 | heart process (GO:0003015) | 2.76775609 |
| 171 | regulation of plasminogen activation (GO:0010755) | 2.74022836 |
| 172 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.72391288 |
| 173 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.67660288 |
| 174 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67039945 |
| 175 | neuromuscular synaptic transmission (GO:0007274) | 2.65959796 |
| 176 | positive regulation of cation channel activity (GO:2001259) | 2.65762618 |
| 177 | cell communication involved in cardiac conduction (GO:0086065) | 2.64825861 |
| 178 | cellular potassium ion homeostasis (GO:0030007) | 2.63323494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.15577298 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.47848863 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21476817 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.45332590 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04446782 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.42950611 |
| 7 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.24165858 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99065070 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.59667780 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.10304215 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.95330506 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29348556 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05965523 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05398301 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97623357 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.94929918 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.87487273 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86997894 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85440999 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81216485 |
| 21 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81216485 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80958785 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77154333 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72165543 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68817930 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67169216 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67038440 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64782383 |
| 29 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62513117 |
| 30 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62513117 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57011345 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48692382 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48607625 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48372382 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45533103 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41546879 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41003896 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39125659 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34273029 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33486427 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29660078 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27541613 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25958888 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25957705 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24896624 |
| 46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23768311 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21517036 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20943492 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15096179 |
| 50 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13851136 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11276862 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.10750221 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10638568 |
| 54 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09545714 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09353598 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07411474 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06376764 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03791571 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03004458 |
| 60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02062918 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01823828 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01670538 |
| 63 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01581887 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00404514 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00259547 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99815126 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99465792 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 0.98032921 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97962092 |
| 70 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96651042 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96228918 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94695738 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94275844 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94206750 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93059755 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90570849 |
| 77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.90342809 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89551080 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88997803 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87223163 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85856459 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84817008 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84625304 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84078194 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83937771 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83236959 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83177484 |
| 88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83168275 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82867061 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82789137 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82585766 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82363366 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.82242502 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82184972 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82184972 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79829176 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79562954 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77221157 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76641808 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76517757 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75552199 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75372821 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73039289 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72882545 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72783243 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70913971 |
| 107 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.70589943 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68387936 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66300119 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.66183980 |
| 111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65700351 |
| 112 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.64965386 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.64879059 |
| 114 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63984041 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62972247 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.62661660 |
| 117 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.62605947 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62571890 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.62446778 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61202653 |
| 121 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.60902947 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60588073 |
| 123 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60054823 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.59675894 |
| 125 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59626699 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59426119 |
| 127 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59115463 |
| 128 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.58721858 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58361357 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.57355902 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56767142 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56518592 |
| 133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.55615443 |
| 134 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.55120229 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.54664566 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.54169758 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.54032753 |
| 138 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.53780909 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53493843 |
| 140 | CJUN_26792858_Chip-Seq_BT549_Human | 0.53411217 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53036281 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52990599 |
| 143 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.52544878 |
| 144 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.52522353 |
| 145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.52156263 |
| 146 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.51845482 |
| 147 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.51077984 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51050453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.34027831 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.97985448 |
| 3 | MP0005360_urolithiasis | 4.62919543 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.31700014 |
| 5 | MP0005365_abnormal_bile_salt | 4.21779910 |
| 6 | MP0003646_muscle_fatigue | 3.90887279 |
| 7 | MP0000751_myopathy | 3.26299157 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23888142 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.18350196 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.10744554 |
| 11 | MP0009840_abnormal_foam_cell | 2.74036232 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.72352326 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.66081401 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.60106821 |
| 15 | MP0000749_muscle_degeneration | 2.60064464 |
| 16 | MP0003252_abnormal_bile_duct | 2.53137731 |
| 17 | MP0005330_cardiomyopathy | 2.52363108 |
| 18 | MP0004130_abnormal_muscle_cell | 2.29827266 |
| 19 | MP0004270_analgesia | 2.23638936 |
| 20 | MP0005083_abnormal_biliary_tract | 2.23088079 |
| 21 | MP0005332_abnormal_amino_acid | 2.13945146 |
| 22 | MP0003195_calcinosis | 2.04079098 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.96156898 |
| 24 | MP0005670_abnormal_white_adipose | 1.83339405 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 1.82901380 |
| 26 | * MP0002972_abnormal_cardiac_muscle | 1.81960014 |
| 27 | MP0003137_abnormal_impulse_conducting | 1.78163733 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.77473902 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.71844453 |
| 30 | MP0002269_muscular_atrophy | 1.71251393 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.70828520 |
| 32 | MP0003879_abnormal_hair_cell | 1.66253422 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.65985180 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.62844953 |
| 35 | * MP0005385_cardiovascular_system_phenoty | 1.60379839 |
| 36 | * MP0001544_abnormal_cardiovascular_syste | 1.60379839 |
| 37 | MP0006138_congestive_heart_failure | 1.59510287 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.58553041 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.58442828 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.57511217 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.55907559 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.53657529 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.47309281 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.45650089 |
| 45 | MP0000609_abnormal_liver_physiology | 1.44027430 |
| 46 | MP0000747_muscle_weakness | 1.38377385 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.37401707 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.37378251 |
| 49 | MP0000733_abnormal_muscle_development | 1.36072657 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.29938139 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.28532400 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26988101 |
| 53 | MP0005451_abnormal_body_composition | 1.26069908 |
| 54 | MP0004085_abnormal_heartbeat | 1.24962320 |
| 55 | MP0005369_muscle_phenotype | 1.24119977 |
| 56 | MP0008569_lethality_at_weaning | 1.23952388 |
| 57 | MP0003011_delayed_dark_adaptation | 1.20119189 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.19860155 |
| 59 | MP0004484_altered_response_of | 1.12845643 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.11446402 |
| 61 | MP0005503_abnormal_tendon_morphology | 1.09765294 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.08035571 |
| 63 | MP0003635_abnormal_synaptic_transmissio | 1.06754332 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 1.05056167 |
| 65 | MP0002064_seizures | 1.04867850 |
| 66 | MP0002971_abnormal_brown_adipose | 1.04722549 |
| 67 | MP0003279_aneurysm | 1.01976260 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99944641 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.97495881 |
| 70 | MP0003186_abnormal_redox_activity | 0.96604685 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.93464922 |
| 72 | MP0002272_abnormal_nervous_system | 0.91416657 |
| 73 | MP0003828_pulmonary_edema | 0.90983812 |
| 74 | MP0001764_abnormal_homeostasis | 0.90652278 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.89943409 |
| 76 | MP0009643_abnormal_urine_homeostasis | 0.88496217 |
| 77 | MP0003690_abnormal_glial_cell | 0.88468891 |
| 78 | MP0003868_abnormal_feces_composition | 0.88347446 |
| 79 | MP0004233_abnormal_muscle_weight | 0.88240807 |
| 80 | MP0005266_abnormal_metabolism | 0.87605527 |
| 81 | MP0009745_abnormal_behavioral_response | 0.87602981 |
| 82 | MP0005165_increased_susceptibility_to | 0.86983042 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.86903449 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.86581445 |
| 85 | MP0001486_abnormal_startle_reflex | 0.85988756 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.85298155 |
| 87 | MP0003880_abnormal_central_pattern | 0.84680775 |
| 88 | MP0002822_catalepsy | 0.82356555 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.82170036 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.82098180 |
| 91 | MP0009697_abnormal_copulation | 0.81494601 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.80828165 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.79581296 |
| 94 | MP0002063_abnormal_learning/memory/cond | 0.79334960 |
| 95 | MP0005535_abnormal_body_temperature | 0.78615997 |
| 96 | MP0003329_amyloid_beta_deposits | 0.78253151 |
| 97 | MP0000343_altered_response_to | 0.76948288 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.75428287 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.75051424 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.75034900 |
| 101 | MP0005334_abnormal_fat_pad | 0.74427855 |
| 102 | MP0005647_abnormal_sex_gland | 0.73659138 |
| 103 | MP0000604_amyloidosis | 0.73569296 |
| 104 | MP0001661_extended_life_span | 0.73234955 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.71463188 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.70491771 |
| 107 | MP0003075_altered_response_to | 0.69995920 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.69882415 |
| 109 | MP0004510_myositis | 0.69486341 |
| 110 | MP0005166_decreased_susceptibility_to | 0.67545264 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.67326044 |
| 112 | MP0008874_decreased_physiological_sensi | 0.65993329 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.64814178 |
| 114 | MP0000598_abnormal_liver_morphology | 0.64778525 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.64716606 |
| 116 | MP0002128_abnormal_blood_circulation | 0.62369043 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.61530238 |
| 118 | MP0009764_decreased_sensitivity_to | 0.61508015 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 0.60959590 |
| 120 | MP0002254_reproductive_system_inflammat | 0.60375877 |
| 121 | MP0009763_increased_sensitivity_to | 0.60011256 |
| 122 | MP0002933_joint_inflammation | 0.59306919 |
| 123 | MP0003633_abnormal_nervous_system | 0.58607945 |
| 124 | MP0000920_abnormal_myelination | 0.58518773 |
| 125 | MP0002249_abnormal_larynx_morphology | 0.58376353 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.57236617 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.55321440 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.55215480 |
| 129 | MP0002572_abnormal_emotion/affect_behav | 0.54591571 |
| 130 | MP0001958_emphysema | 0.53463325 |
| 131 | MP0005595_abnormal_vascular_smooth | 0.53303023 |
| 132 | * MP0000266_abnormal_heart_morphology | 0.53044131 |
| 133 | MP0004043_abnormal_pH_regulation | 0.52784558 |
| 134 | MP0009115_abnormal_fat_cell | 0.52736731 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.52146378 |
| 136 | MP0005275_abnormal_skin_tensile | 0.51066613 |
| 137 | MP0009046_muscle_twitch | 0.50006065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.97745937 |
| 2 | Nemaline bodies (HP:0003798) | 8.96196990 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.68566091 |
| 4 | Distal arthrogryposis (HP:0005684) | 4.98035380 |
| 5 | Sudden death (HP:0001699) | 4.92922779 |
| 6 | Round ear (HP:0100830) | 4.86390661 |
| 7 | Myopathic facies (HP:0002058) | 4.85069687 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.68631924 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.59370618 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.40520576 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 4.37830497 |
| 12 | Xanthomatosis (HP:0000991) | 4.36268934 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.33749450 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 4.26994202 |
| 15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.22197145 |
| 16 | Ventricular tachycardia (HP:0004756) | 4.20580264 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 4.19505160 |
| 18 | Myoglobinuria (HP:0002913) | 4.17153181 |
| 19 | Ketosis (HP:0001946) | 4.16208314 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.11507318 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.10147031 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.09020434 |
| 23 | Neck muscle weakness (HP:0000467) | 3.98428761 |
| 24 | Distal lower limb muscle weakness (HP:0009053) | 3.97773860 |
| 25 | Hyperammonemia (HP:0001987) | 3.95363874 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.89627315 |
| 27 | Hyperglycinuria (HP:0003108) | 3.84059628 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 3.82572270 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.80969486 |
| 30 | Ketoacidosis (HP:0001993) | 3.78543222 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69448877 |
| 32 | Muscle fiber splitting (HP:0003555) | 3.68859691 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64931642 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 3.55596536 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.55567717 |
| 36 | Hyporeflexia of lower limbs (HP:0002600) | 3.55159520 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.54570054 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.54570054 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 3.52501770 |
| 40 | Atrial fibrillation (HP:0005110) | 3.47531292 |
| 41 | Rimmed vacuoles (HP:0003805) | 3.47082431 |
| 42 | Hypolipoproteinemia (HP:0010981) | 3.47065037 |
| 43 | Lipoatrophy (HP:0100578) | 3.42997273 |
| 44 | Hyperglycinemia (HP:0002154) | 3.41122868 |
| 45 | Abnormality of the calf musculature (HP:0001430) | 3.35972404 |
| 46 | Complement deficiency (HP:0004431) | 3.30048492 |
| 47 | Calcaneovalgus deformity (HP:0001848) | 3.26491972 |
| 48 | EMG: neuropathic changes (HP:0003445) | 3.20430465 |
| 49 | Primary atrial arrhythmia (HP:0001692) | 3.19552140 |
| 50 | Rhabdomyolysis (HP:0003201) | 3.19515994 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.15273604 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14257344 |
| 53 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.13646320 |
| 54 | Subaortic stenosis (HP:0001682) | 3.13646320 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.10979958 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 3.10979958 |
| 57 | Palpitations (HP:0001962) | 3.10832427 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 3.09098679 |
| 59 | Supraventricular tachycardia (HP:0004755) | 3.06518003 |
| 60 | Cerebral edema (HP:0002181) | 3.05223737 |
| 61 | Frequent falls (HP:0002359) | 3.04283263 |
| 62 | Atrioventricular block (HP:0001678) | 3.03552709 |
| 63 | Supraventricular arrhythmia (HP:0005115) | 2.99863723 |
| 64 | Dilated cardiomyopathy (HP:0001644) | 2.97792125 |
| 65 | Areflexia of lower limbs (HP:0002522) | 2.97551651 |
| 66 | Syncope (HP:0001279) | 2.92658763 |
| 67 | Absent phalangeal crease (HP:0006109) | 2.92498803 |
| 68 | Deformed tarsal bones (HP:0008119) | 2.85155740 |
| 69 | Heart block (HP:0012722) | 2.84068672 |
| 70 | EMG: myopathic abnormalities (HP:0003458) | 2.83606410 |
| 71 | Increased connective tissue (HP:0009025) | 2.81472737 |
| 72 | Epidermoid cyst (HP:0200040) | 2.78688532 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.70127660 |
| 74 | Abnormal atrioventricular conduction (HP:0005150) | 2.67358640 |
| 75 | Bundle branch block (HP:0011710) | 2.66789047 |
| 76 | Joint hemorrhage (HP:0005261) | 2.66024745 |
| 77 | Ventricular arrhythmia (HP:0004308) | 2.65814556 |
| 78 | Malignant hyperthermia (HP:0002047) | 2.64985292 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 2.59991540 |
| 80 | Cholelithiasis (HP:0001081) | 2.59031935 |
| 81 | Metabolic acidosis (HP:0001942) | 2.58507904 |
| 82 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56745994 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55379284 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.53205995 |
| 85 | Bulbar palsy (HP:0001283) | 2.53102777 |
| 86 | Hepatic necrosis (HP:0002605) | 2.51163855 |
| 87 | Lethargy (HP:0001254) | 2.50870216 |
| 88 | Generalized muscle weakness (HP:0003324) | 2.50725171 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49307382 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.48659794 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.47973684 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 2.47819904 |
| 93 | Prolonged QT interval (HP:0001657) | 2.47384015 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45960506 |
| 95 | Hypercholesterolemia (HP:0003124) | 2.41823698 |
| 96 | Skin nodule (HP:0200036) | 2.39811442 |
| 97 | Difficulty running (HP:0009046) | 2.39301161 |
| 98 | Fetal akinesia sequence (HP:0001989) | 2.37690043 |
| 99 | Myotonia (HP:0002486) | 2.37012928 |
| 100 | Gowers sign (HP:0003391) | 2.36290159 |
| 101 | Acute encephalopathy (HP:0006846) | 2.34854824 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 2.34337757 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 2.31974077 |
| 104 | Muscle stiffness (HP:0003552) | 2.31938943 |
| 105 | Abnormal finger flexion creases (HP:0006143) | 2.31571950 |
| 106 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30946543 |
| 107 | Hyperbilirubinemia (HP:0002904) | 2.29278611 |
| 108 | Generalized aminoaciduria (HP:0002909) | 2.26341837 |
| 109 | Late onset (HP:0003584) | 2.26218845 |
| 110 | Abnormality of complement system (HP:0005339) | 2.25405770 |
| 111 | Scapular winging (HP:0003691) | 2.23717623 |
| 112 | Fat malabsorption (HP:0002630) | 2.21928182 |
| 113 | Weak cry (HP:0001612) | 2.18794794 |
| 114 | Delayed CNS myelination (HP:0002188) | 2.16123302 |
| 115 | Increased muscle lipid content (HP:0009058) | 2.14406380 |
| 116 | Hip contracture (HP:0003273) | 2.13151874 |
| 117 | Type 1 muscle fiber predominance (HP:0003803) | 2.13142815 |
| 118 | Lower limb amyotrophy (HP:0007210) | 2.12935812 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 2.12811240 |
| 120 | Vomiting (HP:0002013) | 2.09855731 |
| 121 | Difficulty climbing stairs (HP:0003551) | 2.06225806 |
| 122 | Hypoglycemic seizures (HP:0002173) | 2.06145238 |
| 123 | Gout (HP:0001997) | 2.04367502 |
| 124 | Slender build (HP:0001533) | 2.02900802 |
| 125 | Ventricular fibrillation (HP:0001663) | 2.02500517 |
| 126 | Hyperglycemia (HP:0003074) | 2.01803948 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99487045 |
| 128 | Spinal rigidity (HP:0003306) | 1.98608839 |
| 129 | Waddling gait (HP:0002515) | 1.97326356 |
| 130 | Limb-girdle muscle atrophy (HP:0003797) | 1.95245638 |
| 131 | Myocardial infarction (HP:0001658) | 1.92260312 |
| 132 | Abnormality of purine metabolism (HP:0004352) | 1.91986255 |
| 133 | Acute necrotizing encephalopathy (HP:0006965) | 1.91345984 |
| 134 | Vascular calcification (HP:0004934) | 1.85950895 |
| 135 | Hepatocellular necrosis (HP:0001404) | 1.84940938 |
| 136 | Fatigable weakness (HP:0003473) | 1.84294372 |
| 137 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84294372 |
| 138 | Proximal amyotrophy (HP:0007126) | 1.83490743 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.81582599 |
| 140 | Cholecystitis (HP:0001082) | 1.81582599 |
| 141 | Lactic acidosis (HP:0003128) | 1.81200506 |
| 142 | Hyperkalemia (HP:0002153) | 1.80602798 |
| 143 | Systemic lupus erythematosus (HP:0002725) | 1.78886649 |
| 144 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78586595 |
| 145 | Abnormality of the calcaneus (HP:0008364) | 1.73403072 |
| 146 | Progressive muscle weakness (HP:0003323) | 1.72802157 |
| 147 | Limited hip movement (HP:0008800) | 1.71321009 |
| 148 | Muscular dystrophy (HP:0003560) | 1.67821859 |
| 149 | Myokymia (HP:0002411) | 1.65976947 |
| 150 | Abnormal EKG (HP:0003115) | 1.64871191 |
| 151 | Obstructive sleep apnea (HP:0002870) | 1.63502062 |
| 152 | Ankle clonus (HP:0011448) | 1.62775163 |
| 153 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.60223559 |
| 154 | Nonprogressive disorder (HP:0003680) | 1.55899205 |
| 155 | Oligomenorrhea (HP:0000876) | 1.54062363 |
| 156 | Exercise intolerance (HP:0003546) | 1.53217278 |
| 157 | Focal motor seizures (HP:0011153) | 1.49951336 |
| 158 | Facial diplegia (HP:0001349) | 1.49501980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.05009823 |
| 2 | TTN | 4.40752152 |
| 3 | PHKG2 | 3.68773102 |
| 4 | PHKG1 | 3.68773102 |
| 5 | OBSCN | 3.58169811 |
| 6 | LMTK2 | 3.44699740 |
| 7 | MYLK | 3.04822434 |
| 8 | TRIB3 | 3.04235145 |
| 9 | SIK1 | 2.71954806 |
| 10 | PKN2 | 2.62653038 |
| 11 | PDK4 | 2.52879644 |
| 12 | PDK3 | 2.52879644 |
| 13 | PINK1 | 2.21273640 |
| 14 | MARK1 | 1.96063912 |
| 15 | ERN1 | 1.95694277 |
| 16 | PIK3CA | 1.92274840 |
| 17 | INSRR | 1.91026838 |
| 18 | DMPK | 1.88515009 |
| 19 | MUSK | 1.88290973 |
| 20 | FGFR4 | 1.85258437 |
| 21 | TIE1 | 1.82011170 |
| 22 | PAK6 | 1.47725082 |
| 23 | PDK2 | 1.46328363 |
| 24 | MAPK12 | 1.38465133 |
| 25 | NEK1 | 1.36763997 |
| 26 | MAP3K7 | 1.30455322 |
| 27 | PRPF4B | 1.29268506 |
| 28 | NTRK3 | 1.18253415 |
| 29 | PRKAA2 | 1.15125893 |
| 30 | MAP2K4 | 1.12488620 |
| 31 | FLT3 | 1.11215536 |
| 32 | PIK3CG | 1.10672260 |
| 33 | PAK3 | 1.09706207 |
| 34 | STK38L | 1.06355360 |
| 35 | ARAF | 1.02548497 |
| 36 | MAP2K3 | 1.02520331 |
| 37 | LIMK1 | 1.01649247 |
| 38 | STK24 | 1.01314084 |
| 39 | PRKD1 | 1.01112727 |
| 40 | UHMK1 | 0.93078970 |
| 41 | PRKAA1 | 0.89959557 |
| 42 | RIPK1 | 0.89366425 |
| 43 | EEF2K | 0.88098566 |
| 44 | EPHB1 | 0.87665250 |
| 45 | PTK6 | 0.87471625 |
| 46 | MAP3K3 | 0.86969390 |
| 47 | ROCK1 | 0.86622450 |
| 48 | CAMK2B | 0.86450840 |
| 49 | CAMK2D | 0.86213312 |
| 50 | KSR2 | 0.83699168 |
| 51 | NEK9 | 0.81929156 |
| 52 | MAPK11 | 0.81162251 |
| 53 | DYRK1B | 0.79140856 |
| 54 | LATS1 | 0.78271085 |
| 55 | GRK5 | 0.74813468 |
| 56 | CAMK1D | 0.72242054 |
| 57 | MAP3K13 | 0.72235893 |
| 58 | GRK7 | 0.71892898 |
| 59 | PKN1 | 0.71227683 |
| 60 | CAMK2G | 0.70952485 |
| 61 | KDR | 0.70521567 |
| 62 | PRKD3 | 0.69951618 |
| 63 | MOS | 0.69017499 |
| 64 | MARK2 | 0.68877239 |
| 65 | CAMK4 | 0.68085214 |
| 66 | TGFBR2 | 0.67647068 |
| 67 | CDC42BPA | 0.67124242 |
| 68 | SGK3 | 0.66955149 |
| 69 | ERBB4 | 0.66817559 |
| 70 | PDGFRA | 0.66803968 |
| 71 | MAP3K5 | 0.66264058 |
| 72 | NME1 | 0.64880435 |
| 73 | MAP3K11 | 0.58649450 |
| 74 | DAPK3 | 0.58510216 |
| 75 | ILK | 0.57205245 |
| 76 | * PRKACG | 0.56878663 |
| 77 | SGK2 | 0.54772429 |
| 78 | SGK1 | 0.53648733 |
| 79 | CAMKK1 | 0.53509417 |
| 80 | MAP2K6 | 0.52773264 |
| 81 | PTK2B | 0.52492811 |
| 82 | STK38 | 0.52415989 |
| 83 | CCNB1 | 0.52010164 |
| 84 | MAPKAPK3 | 0.51075189 |
| 85 | CDK5 | 0.50626355 |
| 86 | JAK2 | 0.50272037 |
| 87 | MST1R | 0.50257335 |
| 88 | JAK1 | 0.50007528 |
| 89 | MAPK4 | 0.49683005 |
| 90 | PDPK1 | 0.49572305 |
| 91 | RPS6KA3 | 0.49455076 |
| 92 | EPHA3 | 0.49285797 |
| 93 | ICK | 0.49008799 |
| 94 | ABL2 | 0.48677609 |
| 95 | CAMK2A | 0.48645130 |
| 96 | PRKACB | 0.48281618 |
| 97 | MAPK7 | 0.48277242 |
| 98 | MAPK10 | 0.47621099 |
| 99 | CAMK1G | 0.46736225 |
| 100 | MAP3K9 | 0.45860838 |
| 101 | NTRK2 | 0.44803045 |
| 102 | MAP3K1 | 0.44093496 |
| 103 | LATS2 | 0.42540759 |
| 104 | MAPK13 | 0.42471774 |
| 105 | ZAK | 0.42353793 |
| 106 | * PRKACA | 0.41846753 |
| 107 | DAPK2 | 0.41198730 |
| 108 | EPHB2 | 0.39512793 |
| 109 | STK11 | 0.39236088 |
| 110 | WNK4 | 0.38235000 |
| 111 | TNK2 | 0.38229416 |
| 112 | PRKCH | 0.37997196 |
| 113 | SGK494 | 0.37117866 |
| 114 | SGK223 | 0.37117866 |
| 115 | TYK2 | 0.37006099 |
| 116 | CAMK1 | 0.36510604 |
| 117 | TRPM7 | 0.36307224 |
| 118 | MAP3K6 | 0.35481328 |
| 119 | TBK1 | 0.34986766 |
| 120 | EPHA4 | 0.34306023 |
| 121 | PRKCE | 0.34037221 |
| 122 | ROCK2 | 0.33514264 |
| 123 | MAP2K1 | 0.32245534 |
| 124 | MAP2K2 | 0.31510759 |
| 125 | RPS6KL1 | 0.31410735 |
| 126 | RPS6KC1 | 0.31410735 |
| 127 | TAOK3 | 0.31098199 |
| 128 | PDK1 | 0.30226191 |
| 129 | TESK1 | 0.29970244 |
| 130 | RET | 0.29715554 |
| 131 | AKT2 | 0.29024954 |
| 132 | TAOK2 | 0.28346162 |
| 133 | PRKG1 | 0.27493463 |
| 134 | MINK1 | 0.27413452 |
| 135 | FGFR2 | 0.27278874 |
| 136 | PRKG2 | 0.27039969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.72965735 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37214277 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18075011 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02133126 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90526985 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.84512928 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83268902 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69861792 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63254135 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60341220 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.48445465 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47780320 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38094828 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36763756 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22248137 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15433117 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00097104 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93140541 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.89977219 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84573444 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81278866 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70537522 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64521345 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63387097 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62493881 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61298287 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55867117 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50616585 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45422959 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44049087 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41711426 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41516626 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41204124 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39010132 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34327868 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32752906 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32317182 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.28331999 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21961272 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20421267 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19890554 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18840672 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17641555 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14157219 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.12284417 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11909680 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09306122 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08959193 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08549804 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.08204845 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07998198 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07245929 |
| 53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.06439037 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05875296 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 1.04374468 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03247726 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03203066 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01691782 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98307743 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97298422 |
| 61 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96022466 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94730694 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91601748 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90295140 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90203610 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88676586 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.88375597 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84726536 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.84555818 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76426700 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75254529 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74913132 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.71524804 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.69508495 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67102315 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66908545 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66187356 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65752814 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65349748 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64883180 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64625491 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.64474688 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.64194330 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62029110 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59411853 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.57895580 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57012312 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56218949 |
| 89 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55073434 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54822421 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52844064 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51506082 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51492726 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50994470 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50248723 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49148905 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47424117 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46981720 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46550666 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43113857 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.42380252 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42330097 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42137892 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41886817 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41597392 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39593625 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37929240 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36722239 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35399909 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35026693 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.33931150 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31875506 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31852857 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31744631 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.29890895 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.26744995 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21446815 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.18525490 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14489633 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12279759 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11009224 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08377878 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05919972 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05590983 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04388957 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.04092683 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01508971 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.00652004 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0403348 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0391266 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0236995 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0140496 |

